Susan Hasty, Publisher
Table of Contents . . . November 11th, 1996Non-Subscriber - Summaries Only
Vectors (Development) - HIV-Based Lentiviral Vector Sustains Efficient Gene Expression In Vivo
Vectors (Development) - Manipulation of Recombinant Rabies Virus Pseudotypes Specifies Cell Targeting
Cancer (Diagnostics) - Collaborative Agreement Entered on Gene-Based Diagnostics
Cancer Gene Therapy - Multidrug Resistance Reversal Via Cytokine Gene Transfer
Cystic Fibrosis - Cytofectin Technology Licensed To Treat CF
Cystic Fibrosis - Positive Phase I AAV-CFTR Trials Announced
Genomic Research - Strides Made in Face of Societal Fear and Mistrust
HIV Vaccines - Setback for British Biotech's Therapeutic AIDS Vaccine
Industry News (Joint Venture) - Patent License Agreement Signed for Stem Cell Technology
Industry News (Patents and Technologies) - Patents Issued for Transgenic Mice Producing Human Antibodies
Influenza Vaccines - Oral Vaccinia Recombinant Protect Mice from Flu
Ophthalmology - Experts Predict Hi-Tech Future
Spinocerebellar Ataxia Type 2 - Ataxia Linked to Newly Found Gene
Tissue Engineering - Skin Substitutes Successfully Modified for Delivery of Therapeutics
Animal Models - "Models of Human Platelet Gene Expression In Vivo."
Transfusion Medicine (Animal Models) - "A Murine Model for Human Cord Blood Transplantation."
Hematopoietic Disease - "The Level of mRNA Encoding the Amphotropic Retrovirus Receptor in Mouse and Human Hematopoietic Stem Cells Is Low and Correlates with the Efficiency of Retrovirus Transduction."
Klebsiella pneumonia - "IL-12 Gene Therapy Protects Mice in Lethal Klebsiella pneumonia."
Plasma Cell Tumors - "Suicide Gene Therapy for Plasma Cell Tumors."
Transgenic Technology - "Antisense and Ribozyme Constructs in Transgenic Animals."
Transplantation (Heart) - "Ex vivo Gene Transfer into Myocardium using Replication-Defective Retrovirus."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.